How to Use Thymosin Alpha-1: Immune Support Dosing and Protocol
Complete thymosin alpha-1 guide — dosing (1.6mg twice weekly), immune support protocol, cycle length, and evidence for immune modulation.
Overview
Thymosin Alpha-1 (Tα1) is a naturally occurring thymic peptide that modulates immune function by enhancing T-cell activity, NK cell function, and dendritic cell maturation. It is FDA-approved (as Zadaxin) in several countries for hepatitis B, hepatitis C, and cancer immunotherapy. This guide covers the standard immune support protocol.
What You Need
- Thymosin Alpha-1 vials (1.6mg each)
- Bacteriostatic water (1mL per vial)
- Insulin syringes (U-100)
- Alcohol swabs
Step-by-Step Instructions
Reconstitute the vial
Add 1mL bacteriostatic water to a 1.6mg vial for 1.6mg/mL concentration. The entire vial is typically one dose.
Standard dosing protocol
Clinical dose: 1.6mg SubQ, twice weekly (e.g., Monday and Thursday). This mirrors the FDA-approved Zadaxin dosing for hepatitis. Research protocols range from 1.6mg 1–3x per week.
Run a 6–12 week cycle
Standard immune support cycle: 6–12 weeks. For acute immune support (illness, post-surgery): 4–6 weeks. For chronic immune modulation: 12+ weeks under medical supervision.
Inject subcutaneously
Inject into the abdomen or outer thigh. Thymosin Alpha-1 is well tolerated — injection site reactions are rare.
Monitor immune markers (optional)
If available, track CD4+ T-cell count, NK cell activity, or general immune markers (WBC, lymphocyte count) before and after the cycle to objectively assess response.
Common Mistakes to Avoid
Using Thymosin Alpha-1 for acute infections
Fix: Tα1 is an immune modulator, not an acute anti-infective. It works best as a preventive or recovery tool, not as a treatment for active infections.
Expecting rapid immune improvement
Fix: Immune modulation takes weeks to manifest. Most clinical studies show significant immune improvements after 4–8 weeks of consistent use.
Confusing with Thymosin Beta-4 (TB-500)
Fix: Thymosin Alpha-1 and Thymosin Beta-4 are different peptides with different mechanisms. Alpha-1 is primarily immune-modulating; Beta-4 (TB-500) is primarily tissue repair and anti-inflammatory.
Frequently Asked Questions
Is Thymosin Alpha-1 FDA-approved?
Thymosin Alpha-1 (Zadaxin) is approved in over 35 countries for hepatitis B, hepatitis C, and as a vaccine adjuvant. It is not currently FDA-approved in the United States but is available as a research compound.
Can Thymosin Alpha-1 help with long COVID?
Several small studies and case reports suggest Tα1 may help with long COVID immune dysregulation. Formal clinical trials are ongoing. It is one of the most promising immune-modulating peptides for post-viral syndromes.
Can Thymosin Alpha-1 be stacked with other peptides?
Yes — Tα1 is commonly stacked with BPC-157 (for gut-immune axis support) and epithalon (for longevity protocols). It is compatible with most other peptides.
Peptides Covered in This Guide
Related Guides
Not sure which peptide is right for you?
Take our 5-minute quiz to get a personalized peptide recommendation based on your biology and goals.